Dasatinib 100mg tablets
NHS hospitals in England used £16,679,084 of indicative cost of Dasatinib 100mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 12.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dasatinib 100mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dasatinib 100mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Croydon Health Services Nhs Trust | £1,252,480 |
| Barts Health Nhs Trust | £713,997 |
| Derby Teaching Hospitals Nhs Found Trust | £606,033 |
| Western Sussex Hospitals Nhs Found Trust | £485,628 |
| Oxford University Hospitals Nhs Ft | £480,869 |
| Univ Hpl B/Ham Nhs Foundation Trust | £427,012 |
| South Tyneside And Sunderland Nhs Ft | £416,491 |
| Salford Royal Nhs Foundation Trust | £338,003 |
| Manchester University Nhs Ft | £326,647 |
| University Hpls Of Leicester Nhs Trust | £325,645 |
The primary-care picture
Dasatinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Dasatinib medicine page.